Skip to main content

FDA Clears 23andMe For All Health and Carrier Traits Testing

 Things are looking up for 23andMe. Right off a fresh $115 million cash infusion, the Food and Drug Administration is giving the direct-to-consumer DNA company the green light to include health and carrier traits, along with ancestry reports. This was not the scenario two years ago when the FDA put a moratorium on 23andMe’s ability to provide any health information associated with… Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.